University of Turku celebrates Professor Shimon Sakaguchi’s Nobel prize
Professor Shimon Sakaguchi, winner of the 2025 Nobel Prize in Medicine, is a visiting professor at the IMMUNOCAPs project that profiles research at the University of Turku. The news of Sakaguchi’s award was celebrated at Turku.
Professor Shimon Sakaguchi works at the University of Osaka in Japan.He studies the molecular mechanisms involved in the regulation of the immune system. His research has focused in particular on the development and maintenance of regulatory T cells and their role in immune-mediated diseases.
He is currently investigating how human regulatory T cells can be manipulated to control a variety of physiological and pathological immune responses. For this purpose, Sakaguchi has also set up a company to develop treatments based on regulatory T cells for immune-mediated diseases.
Sakaguchi has close links with the University of Turku, where he last visited in May 2025.
“I am very happy for Professor Sakaguchi. His pioneering work has been insightful, persistent, and has enabled the development of new immunological therapies,” says Professor Riitta Lahesmaa, Director of the IMMUNOCAPs project.
In addition to Sakaguchi, the Nobel Prize in Medicine was awarded to Mary E. Brunkow and Fred Ramsdell from the United States. They have all been studying how to control the harmful cells that cause autoimmune diseases.
“Their discoveries have laid the foundation for a new field of research and spurred the development of new treatments, for example for cancer and autoimmune diseases,” is stated in the award justifications.
The IMMUNOCAPs (Capitalising Immunity to Combat Disease) project led by Lahesmaa focuses on studying the immune system. The aim is to develop new methods to diagnose and treat immune-mediated diseases. IMMUNOCAPs is part of the InFLAMES research flagship and is also part of the University’s health, diagnostics and drug development multidisciplinary research theme.
The winners of the Nobel Prize for Medicine were announced by the Karolinska Institutet on Monday afternoon.
Recent Posts
- New Funding for our Centre’s Researchers Warm congratulations to all for their funding! Cancer Foundation Finland Project grants Travel grants The Read moreDecember 12, 2025
- Sami Ventelä and Jukka Westermarck recognized by Medical Association Duodecim for their influential work. Medical association Duodecim selects each year persons that have been most influential in the field Read moreDecember 11, 2025
- Our affiliated Group Leader Rafa Najumudeen secures ERC Consolidator Grant The European Research Council (ERC) has awarded a Consolidator Grant to our affiliated Group Leader, Read moreDecember 9, 2025
- New computational tool helps scientists interpret complex single-cell data Researchers from Laura Elo’s group, have developed a new computational method to interpret complex single-cell Read moreNovember 17, 2025
- Carlos Rogério Figueiredo received the Young Investigator Award Carlos Rogério Figueiredo has received the Young Investigator Award from the Scandinavian Society for Immunology. Read moreNovember 4, 2025
- Participate to Open Hardware Workshop, sign up now! Access to research hardware remains a global challenge and it impacts also researchers in high-income Read moreNovember 3, 2025